Contact Us / Sitemap / Directions / Patients and Visitors / Career Opportunities / Medical Staff
1-866-WINTHROP
pay your hospital bill pay your doctor's bill financial assistance policy
Winthrop University Hospital

Metformin Prostate Cancer Adjuvant Trial

Summary

Winthrop University Hospital Clinical Trials Center is conducting a clinical research study for men ages 18 and older who have biopsy proven Prostate Cancer.
This study will examine the effect that Metformin Hydrochloride has on Prostate Specific Antigen levels in men with Prostate Cancer.

Description

Metformin therapy for patients diagnosed with Prostate Cancer who have been treated with either radiation therapy or surgery, who have indicators of high risk disease, or who have a rising Prostate Specific Antigen after treatment.
Eligible participants will receive study-related medical examinations, research medication and laboratory tests at no cost, while they are participating in this clinical research study.

Inclusion/exclusion


To be eligible for this clinical research study you must:
• Be 18 years old
• Be diagnosed with Prostate Cancer
• Have been treated with Radiation Therapy or Surgery
• Not have evidence of metastatic prostate cancer or a diagnosis of Type I Diabetes

Principal Investigator

Aaron Katz, MD

Department

Winthrop University Hospital Department of Urology

Email

ktietjen@winthrop.org

Other Contact

Kaitlin Tietjen Kosinski, BS, MS
Urology Research Coordinator
222 Station Plaza North, Suite 408
Mineola, NY 11501
Telephone: 516-663-4721
Contact Us / Sitemap / Directions / Career Opportunities / Financial Assistance / Policies
1-866-WINTHROP
subscribe
Winthrop-University Hospital
259 First Street | Mineola NY 11501 | 516-663-0333


This site provides information as a resource. It is not a substitute for professional medical advice.
Always consult a physician or healthcare provider for treatment and guidance toward good health.
Copyright © 2014 Winthrop-University Hospital. All rights reserved.
Web site by: Long Island Web Design
page-bottom